We are live on ! Find out more
GP

Geneva Partners Portfolio holdings

AUM $208M
1-Year Est. Return 72.91%
This Fund
S&P 500
This Quarter Est. Return
+9.97%
1 Year Est. Return
+72.91%
3 Year Est. Return
+251.81%
5 Year Est. Return
+429.32%
10 Year Est. Return
AUM
$130M
AUM Growth
+$4.13M
Cap. Flow
-$5.44M
Cap. Flow %
-4.17%
Top 10 Hldgs %
32.85%
Holding
99
New
14
Increased
20
Reduced
45
Closed
13

Top Buys

Rank Stock Value
1
DG icon
Dollar General
DG
+$3.33M
2
ADSK icon
Autodesk
ADSK
+$2.73M
3
ITT icon
ITT
ITT
+$1.43M
4
TMO icon
Thermo Fisher Scientific
TMO
+$1.32M
5
TT icon
Trane Technologies
TT
+$1.31M

Sector Composition

Rank Sector Weight
1 Healthcare 16.96%
2 Financials 15.45%
3 Technology 14.58%
4 Industrials 13.22%
5 Consumer Discretionary 7.25%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FTV icon
51
Fortive
FTV
$18.2B
$837K 0.64%
15,756
-530
-3% -$27.2K
V icon
52
Visa
V
$701B
$768K 0.59%
5,119
-10
-0.2% -$1.42K
GRUB
53
DELISTED
Just Eat Takeaway.com N.V. American Depositary Shares
GRUB
$749K 0.58%
+2,703
New +$697K
CCI icon
54
Crown Castle
CCI
$34.6B
$734K 0.56%
6,596
-708
-10% -$78.8K
IEUR icon
55
iShares Core MSCI Europe ETF
IEUR
$8.8B
$730K 0.56%
15,229
-4,788
-24% -$231K
AMT icon
56
American Tower
AMT
$83.5B
$723K 0.56%
4,977
-750
-13% -$110K
COO icon
57
Cooper Companies
COO
$14.2B
$713K 0.55%
9,896
-844
-8% -$54.2K
HQY icon
58
HealthEquity
HQY
$8.71B
$665K 0.51%
7,040
-1,280
-15% -$110K
IBDM
59
DELISTED
iShares iBonds Dec 2021 Term Corporate ETF
IBDM
$662K 0.51%
27,160
-35,975
-57% -$876K
IEMG icon
60
iShares Core MSCI Emerging Markets ETF
IEMG
$144B
$582K 0.45%
11,239
-79,559
-88% -$4.15M
DEO icon
61
Diageo
DEO
$49.6B
$564K 0.43%
3,981
-4,384
-52% -$629K
DHR icon
62
Danaher
DHR
$138B
$563K 0.43%
5,849
BTT icon
63
BlackRock Municipal 2030 Target Term Trust
BTT
$1.44B
$529K 0.41%
25,545
+203
+0.8% +$4.32K
LMT icon
64
Lockheed Martin
LMT
$131B
$523K 0.4%
1,512
-25
-2% -$8.07K
IDV icon
65
iShares International Select Dividend ETF
IDV
$8.31B
$500K 0.38%
15,315
-5,853
-28% -$191K
PFE icon
66
Pfizer
PFE
$143B
$483K 0.37%
+11,556
New +$445K
SPLK
67
DELISTED
Splunk Inc
SPLK
$480K 0.37%
+3,970
New +$440K
MCO icon
68
Moody's
MCO
$83.7B
$460K 0.35%
2,750
-2,615
-49% -$460K
IWF icon
69
iShares Russell 1000 Growth ETF
IWF
$117B
$439K 0.34%
11,264
+1,348
+14% +$51K
IBDO
70
DELISTED
iShares iBonds Dec 2023 Term Corporate ETF
IBDO
$435K 0.33%
17,896
-45,076
-72% -$1.1M
CTAS icon
71
Cintas
CTAS
$86.6B
$415K 0.32%
8,400
QUAL icon
72
iShares MSCI USA Quality Factor ETF
QUAL
$45.7B
$361K 0.28%
4,000
HYG icon
73
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$15.9B
$347K 0.27%
4,015
-8,990
-69% -$772K
RP
74
DELISTED
RealPage, Inc.
RP
$330K 0.25%
+5,000
New +$298K
IWR icon
75
iShares Russell Mid-Cap ETF
IWR
$55.9B
$287K 0.22%
5,200

Similar funds

Geneva Partners's Q3 2018 Portfolio in Review

As of Q3 2018, Geneva Partners held 99 positions worth $130M, up 3.3% from $126M the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Geneva Partners withdrew a net $5.44M in Q3 2018, closing 13 positions and reducing 45 holdings. Its most notable exit was Vanguard FTSE All-World ex-US Small-Cap Index Fund, an estimated $1.16M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 17% of assets, up from 13% a quarter earlier, followed by Financials and Technology.

Against the trend, Geneva Partners opened a new position in Dollar General worth $3.5M.

  • Geneva Partners's largest Q3 2018 buy was Dollar General: 32,020 shares worth $3.5M.
  • Geneva Partners added most to Trane Technologies in Q3 2018, an estimated $1.31M increase.
  • Geneva Partners's biggest Q3 2018 reduction was iShares Core MSCI Emerging Markets ETF, cutting an estimated $4.15M.
  • Geneva Partners fully exited Vanguard FTSE All-World ex-US Small-Cap Index Fund in Q3 2018, selling an estimated $1.16M.
  • Geneva Partners's ten largest holdings make up 33% of its $130M portfolio in Q3 2018.
  • Geneva Partners opened 14 new positions and closed 13 in Q3 2018.
  • Geneva Partners's portfolio value rose 3.3% quarter-over-quarter to $130M.

Based on Geneva Partners's 13F filing for Q3 2018, filed 23 Oct 2018.